🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with numerous of members share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.

Several experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at residence.

After moments of joining one group, a vendor shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Within these groups, messages show dark colored parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the research behind this drug is valid, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially significant health risks”.